Save (intracardiac pressure monitor)

2023: Product Announcement

On November 8, 2023, Swedish startup Acorai introduced non-invasive pressure measurement technology in the heart chambers. A sensory system called Save is designed to simplify and make more effective the treatment of heart failure.

Outwardly, the device looks like a regular smartphone. It is equipped with a range of different sensors including seismic, acoustic, optical and electrical. These sensors collect information about the work of the patient's heart, on the basis of which the pressure in the ventricles and atria is calculated. Cardiac data is collected in real time. The Acorai platform, based on machine learning algorithms, is said to use one of the largest sets of clinical indicators in the relevant field. The obtained values ​ ​ are displayed in visual form on the built-in display.

Acorai Save

The Acorai platform is easy to use. It is enough to apply the device to the patient's chest for several minutes, after which the device will display information about the pressure in the heart chambers. It is noted that the Save sensor system can generate extensive data for medical professionals. Practitioners, general practitioners and nurses can use the device with little to no prior training.

Startup Acorai received a grant of €2.3 million from the European Innovation Council. In the future, the company will be provided with another €10 million for the further development of the Save platform and its commercialization. As of November 2023, the Acorai system is in a clinical trial phase involving 1,200 patients at 11 scientific and medical centers in,,,, and Sweden Denmark Belgium. Britain USA To Canada It is planned to complete the research in 2024, after which certification of the device will begin.^[1]

Notes